At a glance
ClinicalIndex Comparison RecordN/ACompleted· 52 enrolled
Drug / intervention
CT Scandevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
DMH-Based Plan Evaluation and Inverse Optimization in Radiotherapy
In Brief
A clinical study evaluating CT Scan for Head and Neck Cancer and 2 related conditions. Completed, enrolled 52 participants across 1 site.
Detailed Summary
The hypotheses of the study are as follows: * Mass-based inverse optimization in radiotherapy treatment planning will result in a reduction of normal tissue and organs at risk (OAR) doses for desired prescription therapeutic doses to the targets. * Dose-mass histograms (DMHs) may be more relevant to radiotherapy treatment planning and treatment plan assessment than the standard of care, realized through dose-volume histograms (DVHs)
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHead and Neck Cancer, Lung Cancer, Prostate Cancer
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJun 2015
First PostedJan 2016
Primary CompletionApr 2019
TodayJul 2026
First PostedJan 26, 2016
Enrollment StartJun 19, 2015
Primary CompletionApr 4, 2019
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 10.4 years ago
Interventions
CT Scandevice